Quick Answer
Biodexa Pharmaceuticals Plc reported Total Assets of $18.18 million for fiscal year 2025.
Biodexa Pharmaceuticals Plc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $18.18M | +23.0% |
| 2024 | $14.78M | +40.2% |
| 2023 | $10.54M | +90.8% |
| 2022 | $5.53M | -57.2% |
| 2021 | $12.91M | +31.5% |
| 2020 | $9.82M | -68.2% |
| 2019 | $30.89M | +51.1% |
| 2018 | $20.44M | -58.5% |
| 2017 | $49.22M | -13.2% |
| 2016 | $56.69M | -11.5% |
| 2015 | $64.04M | — |
- Biodexa Pharmaceuticals Plc showed an increase of +23.0% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Biodexa Pharmaceuticals Plc’s total assets has declined by 71.6% (from $64.04 million to $18.18 million).
- The most recent figure is from Biodexa Pharmaceuticals Plc’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: